Figure 3.
Forest plot of overall survival HRs across clinicopathological subgroups. For the few patients who received lenvatinib, one comparison group had zero events and the HR could not be confidently estimated using Cox proportional hazards regression. ECOG, Eastern Cooperative Oncology Group performance status; ICI, immune checkpoint inhibitor; IMDC, International Metastatic RCC Database Consortium; LDH, lactate dehydrogenase; RCC, renal cell carcinoma.
